65,437 trials
Attention Deficit Disorder · Attention Deficit Hyperactivity Disorder
Primary: Change in Score on Barkley Adult ADHD Rating Scale-IV (BAARS-IV) — 23.27; 23.1 score on a scale
Ventricular Tachycardia
Primary: Number of Participants With Device Detected Ventricular Tachycardia/Ventricular Fibrillation Episodes — 31; 97 Participants
Multiple Sclerosis
Primary: The Primary Outcome Measure is the Number of "Combined Active Lesions" (CAL) by Monthly MRI at the Conclusion of the Study. — 0.63; 0.58 Average number of lesions per…
Proximal Humeral Fracture
Primary: Constant Scale Evaluation at 3 Months and 12 Months From the Date of Trauma — 40.1; 51.8 units on a scale — p=<0.01
Health Volunteers, Huntington Disease
Primary: Sigma-1 Receptor Occupancy — 91.21; 87.19; 86.67; 77.96 percentage of receptor occupancy
Healthy
Primary: Pharmacokinetics (PK): Insulin Lispro Area Under the Serum Concentration Versus Time Curve From Time Zero to 10 Hours Postdose (AUC[0-10h]) — 708; 1580; 1600 picomole *…
Knee Arthritis
Primary: Radiological Assessment of Component Positioning — 0.9; 1.8; 9.1; 8.8 Degrees — p=<0.05
Mental Health Wellness 1
Primary: First Responders Who Provided Qualitative Data — 145 participants
HIV Infection
Primary: Number of Participants With Local and Systemic Reactogenicity Signs and Symptoms — 3; 8; 4; 5 Participants
Peripheral Artery Disease
Primary: Six-minute Walk Distance — -6.4; 34.5; -15.1 meters
SARS-CoV-2 Infection
Primary: Preliminary Safety and Tolerability of CT-P59 — 0; 2; 1; 0 Participants
Cutaneous Melanoma · Melanoma · Melanoma of Unknown Primary
Primary: Immune T-cell Response to NY-ESO-1 — 15; 10 Participants
Chronic Disease · Rheumatic Diseases
Primary: Perceived Usefulness of the Application — 12; 0; 0; 0 Participants
COVID-19
Primary: Percentage of Participants Who Experience COVID-19 Related Hospitalization or Death From Any Cause — 0.9; 0.9; 0.9 Percentage of participants
Sleep Apnea, Obstructive
Primary: Accuracy of HST Compared to ALT (ApneaLink Lab Testing) and PSG (Polysomnography) — 6.2; 10.9; 11.6; 16.9 events per hour